Self-reported side effects of COVID-19 vaccines among the public

References

• Adedeji-Adenola, H., Olugbake, O. A., & Adeosun, S. A. (2022). Factors influencing COVID-19 vaccine uptake among adults in Nigeria. PLoS One, 17(2), e0264371. https://doi.org/10.1371/journal.pone.0264371
   PubMed Web of Science ®Google Scholar
• Alekseeva, E., Sominskaya, I., Skrastina, D., Egorova, I., Starodubova, E., Kushners, E., Mihailova, M., Petrakova, N., Bruvere, R., Kozlovskaya, T., Isaguliants, M., & Pumpens, P. (2009). Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: Advantages of the heterologous DNA prime, protein boost immunization regimen. Genetic Vaccines and Therapy, 7(1), 1–17. https://doi.org/10.1186/1479-0556-7-7
   PubMedGoogle Scholar
• Alemayehu, A., Demissie, A., Yusuf, M., Abdullahi, Y., Abdulwehab, R., Oljira, L., & Feleke, D. (2022). COVID-19 vaccine side effect: Age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia: A community-based study. SAGE Open Medicine, 10, 20503121221108616.
   Web of Science ®Google Scholar
• Alghamdi, A. N., Alotaibi, M. I., Alqahtani, A. S., Al Aboud, D., & Abdel-Moneim, A. S. (2021). BNT162b2 and ChAdOx1 SARS-CoV-2 post-vaccination side-effects among Saudi vaccinees. Frontiers in Medicine, 8, 760047. https://doi.org/10.3389/fmed.2021.760047
   PubMed Web of Science ®Google Scholar
• Al-Kassmy, J., Pedersen, J., & Kobinger, G. (2020). Vaccine candidates against coronavirus infections. Where does COVID-19 stand? Viruses, 12(8), 861. https://doi.org/10.3390/v12080861
   PubMed Web of Science ®Google Scholar
• Almalki, O. S., Khalifa, A. S., Alhemeidi, O. F., Ewis, A. A., Shady, A. M., & Abdelwahab, S. F. (2022). Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi arabia: A web-based survey. Frontiers in Pharmacology, 13, 1006333. https://doi.org/10.3389/fphar.2022.1006333
   PubMed Web of Science ®Google Scholar
• Alshahrani, M., & Alqahtani, A. (2022). Side effects of mixing vaccines against COVID-19 infection among Saudi population. Vaccines, 10(4), 519. https://doi.org/10.3390/vaccines10040519
   Web of Science ®Google Scholar
• Banovac, M., Candore, G., Slattery, J., Houÿez, F., Haerry, D., Genov, G., & Arlett, P. (2017). Patient reporting in the EU: Analysis of EudraVigilance data. Drug Safety, 40(7), 629–645. https://doi.org/10.1007/s40264-017-0534-1
   PubMed Web of Science ®Google Scholar
• Batarseh, Y. S., Darwish ElHajji, F. W., Shammas, S., Darwish, R. M., Fakhoury, R., Al Haj Ahmad, M., Al Rusasi, A., & Jarrar, L. (2021). Perception and attitude of the public on vaccine practices and pharmacists as immunizers in Jordan. Journal of Pharmaceutical Health Services Research, 12(2), 114–121. https://doi.org/10.1093/jphsr/rmaa009
   Web of Science ®Google Scholar
• Batteux, E., Mills, F., Jones, L. F., Symons, C., & Weston, D. (2022). The effectiveness of interventions for increasing COVID-19 vaccine uptake: A systematic review. Vaccines, 10(3), 386. https://doi.org/10.3390/vaccines10030386
   Web of Science ®Google Scholar
• Bloom, D. E., Cadarette, D., & Ferranna, M. (2021). The societal value of vaccination in the age of COVID-19. American Journal of Public Health, 111(6), 1049–1054. https://doi.org/10.2105/AJPH.2020.306114
   PubMed Web of Science ®Google Scholar
• Borobia, A. M., Carcas, A. J., Pérez-Olmeda, M., Castaño, L., Bertran, M. J., García-Pérez, J., Campins, M., Portolés, A., González-Pérez, M., García Morales, M. T., Arana-Arri, E., Aldea, M., Díez-Fuertes, F., Fuentes, I., Ascaso, A., Lora, D., Imaz-Ayo, N., Barón-Mira, L. E., Agustí, A., … Torvisco, J. M. (2021). Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. The Lancet, 398(10295), 121–130. https://doi.org/10.1016/S0140-6736(21)01420-3
   PubMed Web of Science ®Google Scholar
• Bouvy, J. C., De Bruin, M. L., & Koopmanschap, M. A. (2015). Epidemiology of adverse drug reactions in Europe: A review of recent observational studies. Drug Safety, 38(5), 437–453. https://doi.org/10.1007/s40264-015-0281-0
   PubMed Web of Science ®Google Scholar
• Camacho Moll, M. E., Salinas Martínez, A. M., Tovar Cisneros, B., García Onofre, J. I., Navarrete Floriano, G., & Bermúdez de León, M. (2022). Extension and severity of self-reported side effects of seven COVID-19 vaccines in Mexican population. Frontiers in Public Health, 10, 834744. https://doi.org/10.3389/fpubh.2022.834744
   PubMed Web of Science ®Google Scholar
• Cuschieri, S., Borg, M., Agius, S., Souness, J., Brincat, A., & Grech, V. (2021). Adverse reactions to Pfizer-BioNTech vaccination of healthcare workers at Malta's state hospital. International Journal of Clinical Practice, 75(10), e14605. https://doi.org/10.1111/ijcp.14605
   PubMedGoogle Scholar
• Di Resta, C., Ferrari, D., Viganò, M., Moro, M., Sabetta, E., Minerva, M., Ambrosio, A., Locatelli, M., & Tomaiuolo, R. (2021). The gender impact assessment among healthcare workers in the SARS-CoV-2 vaccination—an analysis of serological response and side effects. Vaccines, 9(5), 522. https://doi.org/10.3390/vaccines9050522
   Web of Science ®Google Scholar
• Doroftei, B., Ciobica, A., Ilie, O.-D., Maftei, R., & Ilea, C. (2021). Mini-review discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics, 11(4), 579. https://doi.org/10.3390/diagnostics11040579
   Web of Science ®Google Scholar
• Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020). Vaccine hesitancy: The next challenge in the fight against COVID-19. European Journal of Epidemiology, 35(8), 775–779. https://doi.org/10.1007/s10654-020-00671-y
   PubMed Web of Science ®Google Scholar
• Drozdzal, S., Rosik, J., Lechowicz, K., Machaj, F., Szostak, B., Przybyciński, J., Lorzadeh, S., Kotfis, K., Ghavami, S., & Łos, M. J. (2021). An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resistance Updates, 59, 100794. https://doi.org/10.1016/j.drup.2021.100794
   PubMed Web of Science ®Google Scholar
• Elnaem, M. H., Mohd Taufek, N. H., Ab Rahman, N. S., Mohd Nazar, N. I., Zin, C. S., Nuffer, W., & Turner, C. J. (2021). COVID-19 vaccination attitudes, perceptions, and side effect experiences in Malaysia: Do age, gender, and vaccine type matter? Vaccines, 9(10), 1156. https://doi.org/10.3390/vaccines9101156
   Web of Science ®Google Scholar
• El-Shitany, N. A., Harakeh, S., Badr-Eldin, S. M., Bagher, A. M., Eid, B. G., Almukadi, H. S., Alghamdi, B. S., Alahmadi, A. A., Hassan, N. A., Sindi, N., Alghamdi, S. A., Almohaimeed, H. M., Mohammedsaleh, Z. M., Al-Shaikh, T. M., Almuhayawi, M. S., Ali, S. S., & El-Hamamsy, M. (2021). Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: A retrospective cross-sectional study. International Journal of General Medicine, 14, 1389–1401. https://doi.org/10.2147/IJGM.S310497
   PubMed Web of Science ®Google Scholar
• Enitan, S. S., Oyekale, A., Akele, R., Olawuyi, K. A., Olabisi, E. O., Nwankit, A. J., Adejumo, E. N., & Enitan, C. B. (2020). Assessment of knowledge, perception and readiness of Nigerians to participate in the COVID-19 vaccine trial. International Journal of Vaccines and Immunization, 4(1), 1–13.
   Google Scholar
• Faasse, K., Gamble, G., Cundy, T., & Petrie, K. J. (2012). Impact of television coverage on the number and type of symptoms reported during a health scare: A retrospective pre–post observational study. Bmj Open, 2(4), e001607. https://doi.org/10.1136/bmjopen-2012-001607
   PubMed Web of Science ®Google Scholar
• Gagneux-Brunon, A., Detoc, M., Bruel, S., Tardy, B., Rozaire, O., Frappe, P., & Botelho-Nevers, E. (2021). Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: A cross-sectional survey. Journal of Hospital Infection, 108, 168–173. https://doi.org/10.1016/j.jhin.2020.11.020
   PubMed Web of Science ®Google Scholar
• Ganesan, S., Al Ketbi, L. M. B., Al Kaabi, N., Al Mansoori, M., Al Maskari, N. N., Al Shamsi, M. S., Alderei, A. S., El Eissaee, H. N., Al Ketbi, R. M., Al Shamsi, N. S., Saleh, K. M., Al Blooshi, A. F., Cantarutti, F. M., Warren, K., Ahamed, F., & Zaher, W. (2022). Vaccine side effects following COVID-19 vaccination among the residents of the UAE—an observational study. Frontiers in Public Health, 10, 876336. https://doi.org/10.3389/fpubh.2022.876336
   PubMed Web of Science ®Google Scholar
• Hatmal, M., Al-Hatamleh, M. A., Olaimat, A. N., Hatmal, M., Alhaj-Qasem, D. M., Olaimat, T. M., & Mohamud, R. (2021). Side effects and perceptions following COVID-19 vaccination in Jordan: A randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines, 9(6), 556. https://doi.org/10.3390/vaccines9060556
   PubMed Web of Science ®Google Scholar
• Hatmal, M., Al-Hatamleh, M. A., Olaimat, A. N., Mohamud, R., Fawaz, M., Kateeb, E. T., Alkhairy, O. K., Tayyem, R., Lounis, M., Al-Raeei, M., Dana, R. K., Al-Ameer, H. J., Taha, M. O., & Bindayna, K. M. (2022). Reported adverse effects and attitudes among Arab populations following COVID-19 vaccination: A large-scale multinational study implementing machine learning tools in predicting post-vaccination adverse effects based on predisposing factors. Vaccines, 10(3), 366. https://doi.org/10.3390/vaccines10030366
   Web of Science ®Google Scholar
• Hervé, C., Laupèze, B., Del Giudice, G., Didierlaurent, A. M., & Tavares Da Silva, F. (2019). The how’s and what’s of vaccine reactogenicity. npj Vaccines, 4(1), 39. https://doi.org/10.1038/s41541-019-0132-6
   PubMed Web of Science ®Google Scholar
• Hillus, D., Schwarz, T., Tober-Lau, P., Vanshylla, K., Hastor, H., Thibeault, C., Jentzsch, S., Helbig, E. T., Lippert, L. J., Tscheak, P., Schmidt, M. L., Riege, J., Solarek, A., von Kalle, C., Dang-Heine, C., Gruell, H., Kopankiewicz, P., Suttorp, N., Drosten, C., … Zvorc, S. (2021). Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: A prospective cohort study. The Lancet Respiratory Medicine, 9(11), 1255–1265. https://doi.org/10.1016/S2213-2600(21)00357-X
   PubMed Web of Science ®Google Scholar
• Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E., & Larson, H. J. (2015). Strategies for addressing vaccine hesitancy–A systematic review. Vaccine, 33(34), 4180–4190. https://doi.org/10.1016/j.vaccine.2015.04.040
   PubMed Web of Science ®Google Scholar
• Jennings, W., Stoker, G., Bunting, H., Valgarðsson, V. O., Gaskell, J., Devine, D., McKay, L., & Mills, M. C. (2021). Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines, 9(6), 593. https://doi.org/10.3390/vaccines9060593
   PubMed Web of Science ®Google Scholar
• Kadali, R. A., Janagama, R., Peruru, S., & Malayala, S. V. (2021). Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. International Journal of Infectious Diseases, 106, 376–381. https://doi.org/10.1016/j.ijid.2021.04.047
   PubMed Web of Science ®Google Scholar
• Krammer, F., Srivastava, K., team, P., & Simon, V. (2021). Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine. MedRxiv. 2021.01.29.21250653.
   Google Scholar
• Lin, K., Roosinovich, E., Ma, B., Hung, C.-F., & Wu, T.-C. (2010). Therapeutic hpv DNA vaccines. Immunologic Research, 47(1-3), 86–112. https://doi.org/10.1007/s12026-009-8141-6
   PubMed Web of Science ®Google Scholar
• Lipsitch, M., & Dean, N. E. (2020). Understanding COVID-19 vaccine efficacy. Science, 370(6518), 763–765. https://doi.org/10.1126/science.abe5938
   PubMed Web of Science ®Google Scholar
• Lu, S. (2009). Heterologous prime–boost vaccination. Current Opinion in Immunology, 21(3), 346–351. https://doi.org/10.1016/j.coi.2009.05.016
   PubMed Web of Science ®Google Scholar
• Luyten, J., Bruyneel, L., & Van Hoek, A. J. (2019). Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument. Vaccine, 37(18), 2494–2501. https://doi.org/10.1016/j.vaccine.2019.03.041
   PubMed Web of Science ®Google Scholar
• Malaysia MoF. (2021). Malaysia’s 2Q 2021 GDP grows by 16.1%; Economy expected to continue on recovery path. https://www.mof.gov.my/portal/en/news/press-release/malaysia-s-2q-2021-gdp-grows-by-16-1-economy-expected-to-continue-on-recovery-path#:~:text=Press%20Release-,Malaysia's%202Q%202021%20GDP%20Grows%20by%2016.1%25%3B,to%20Continue%20on%20Recovery%20Path&text=Bank%20Negara%20Malaysia%20(BNM)%20and,of%202021%20(Q2%202021)
   Google Scholar
• Malaysia MoH. (2021). Clinical guidelines on COVID-19 vaccination in Malaysia (4th ed.).
   Google Scholar
• Maraqa, B., Nazzal, Z., Rabi, R., Sarhan, N., Al-Shakhra, K., & Al-Kaila, M. (2021). COVID-19 vaccine hesitancy among health care workers in Palestine: A call for action. Preventive Medicine, 149, 106618. https://doi.org/10.1016/j.ypmed.2021.106618
   PubMed Web of Science ®Google Scholar
• Mayer, M. H., Dowsett, S. A., Brahmavar, K., Hornbuckle, K., & Brookfield, W. (2010). Reporting adverse drug events. U. S. Pharmacist, 35(4), HS-15–HS-19.
   Google Scholar
• Menni, C., Klaser, K., May, A., Polidori, L., Capdevila, J., Louca, P., Sudre, C. H., Nguyen, L. H., Drew, D. A., Merino, J., Hu, C., Selvachandran, S., Antonelli, M., Murray, B., Canas, L. S., Molteni, E., Graham, M. S., Modat, M., Joshi, A. D., … Spector, T. D. (2021). Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: A prospective observational study. The Lancet Infectious Diseases, 21(7), 939–949. https://doi.org/10.1016/S1473-3099(21)00224-3
   PubMed Web of Science ®Google Scholar
• Mohamed, N. A., Solehan, H. M., Mohd Rani, M. D., Ithnin, M., & Arujanan, M. (2023). Understanding COVID-19 vaccine hesitancy in Malaysia: Public perception, knowledge, and acceptance. PLoS One, 18(4), e0284973.
   PubMed Web of Science ®Google Scholar
• Mohammed, R. A., Garout, R. M., Wahid, S., Ayub, F., ZinAlddin, L. M. F., & Sultan, I. (2021). A survey on the side effects of Pfizer/BioNTech COVID-19 vaccine among vaccinated adults in Saudi arabia. Cureus, 13(11), e19222. https://doi.org/10.7759/cureus.19222
   PubMed Web of Science ®Google Scholar
• Morimoto, T., Gandhi, T. K., Seger, A. C., Hsieh, T. C., & Bates, D. W. (2004). Adverse drug events and medication errors: Detection and classification methods. Quality and Safety in Health Care, 13(4), 306–314. https://doi.org/10.1136/qshc.2004.010611
   PubMedGoogle Scholar
• Nassar, R. I., Alnatour, D., Thiab, S., Nassar, A., El-Hajji, F., & Basheti, I. A. (2022). Short-term side effects of COVID-19 vaccines: A cross-sectional study in Jordan. Human Vaccines & Immunotherapeutics, 18(5), 2082792. https://doi.org/10.1080/21645515.2022.2082792
   PubMed Web of Science ®Google Scholar
• National Institute of Health Malaysia. (n.d.). Clinical update on COVID-19. https://www.nih.gov.my/covid-19/.
   Google Scholar
• Niknam, Z., Jafari, A., Golchin, A., Danesh Pouya, F., Nemati, M., Rezaei-Tavirani, M., & Rasmi, Y. (2022). Potential therapeutic options for COVID-19: An update on current evidence. European Journal of Medical Research, 27(1), 6. https://doi.org/10.1186/s40001-021-00626-3
   PubMed Web of Science ®Google Scholar
• Omeish, H., Najadat, A., Al-Azzam, S., Tarabin, N., Abu Hameed, A., Al-Gallab, N., Abbas, H., Rababah, L., Rabadi, M., Karasneh, R., & Aldeyab, M. A. (2022). Reported COVID-19 vaccines side effects among Jordanian population: A cross sectional study. Human Vaccines & Immunotherapeutics, 18(1), 1981086. https://doi.org/10.1080/21645515.2021.1981086
   PubMed Web of Science ®Google Scholar
• Plotkin, S. A. (2010). Correlates of protection induced by vaccination. Clinical and Vaccine Immunology, 17(7), 1055–1065. https://doi.org/10.1128/CVI.00131-10
   PubMed Web of Science ®Google Scholar
• Potluri, T., Fink, A. L., Sylvia, K. E., Dhakal, S., Vermillion, M. S., vom Steeg, L., Deshpande, S., Narasimhan, H., & Klein, S. L. (2019). Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. npj Vaccines, 4(1), 29. https://doi.org/10.1038/s41541-019-0124-6
   PubMedGoogle Scholar
• Pulendran, B. (2014). Systems vaccinology: Probing humanity's diverse immune systems with vaccines. Proceedings of the National Academy of Sciences of the United States of America, 111(34), 12300–12306. https://doi.org/10.1073/pnas.1400476111
   PubMed Web of Science ®Google Scholar
• Razai, M. S., Chaudhry, U. A. R., Doerholt, K., Bauld, L., & Majeed, A. (2021). COVID-19 vaccination hesitancy. BMJ, 373, n1138. https://doi.org/10.1136/bmj.n1138
   PubMed Web of Science ®Google Scholar
• Riad, A., Pokorná, A., Attia, S., Klugarová, J., Koščík, M., & Klugar, M. (2021a). Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech republic. Journal of Clinical Medicine, 10(7), 1428. https://doi.org/10.3390/jcm10071428
   PubMed Web of Science ®Google Scholar
• Riad, A., Sağıroğlu, D., Üstün, B., Pokorná, A., Klugarová, J., Attia, S., … Klugar, M. (2021b). Prevalence and risk factors of CoronaVac side effects: An independent cross-sectional study among healthcare workers in Turkey. Journal of Clinical Medicine, 10(12), 2629. https://doi.org/10.3390/jcm10122629
   PubMed Web of Science ®Google Scholar
• Saadat, S., Rikhtegaran-Tehrani, Z., Logue, J., Newman, M., Frieman, M. B., Harris, A. D., & Sajadi, M. M. (2021). Single dose vaccination in healthcare workers previously infected with SARS-CoV-2. MedRxiv.
   Google Scholar
• Saeed, B. Q., Al-Shahrabi, R., Alhaj, S. S., Alkokhardi, Z. M., & Adrees, A. O. (2021). Side effects and perceptions following Sinopharm COVID-19 vaccination. International Journal of Infectious Diseases, 111, 219–226. https://doi.org/10.1016/j.ijid.2021.08.013
   PubMed Web of Science ®Google Scholar
• Saeedi, A., Ghaemi, A., Tabarraei, A., Moradi, A., Gorji, A., Semnani, S., Soleimanjahi, H., Adli, A. H., Hosseini, S. Y., & Vakili, M. A. (2014). Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice. Virus Genes, 49(1), 11–21. https://doi.org/10.1007/s11262-014-1070-z
   PubMed Web of Science ®Google Scholar
• Saied, S. M., Saied, E. M., Kabbash, I. A., & Abdo, S. A. E. F. (2021). Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. Journal of Medical Virology, 93(7), 4280–4291. https://doi.org/10.1002/jmv.26910
   PubMed Web of Science ®Google Scholar
• Shekhar, R., Sheikh, A. B., Upadhyay, S., Singh, M., Kottewar, S., Mir, H., Barrett, E., & Pal, S. (2021). COVID-19 vaccine acceptance among health care workers in the United States. Vaccines, 9(2), 119. https://doi.org/10.3390/vaccines9020119
   PubMed Web of Science ®Google Scholar
• Statista Research Department. (2022). Number of adults in Malaysia from 2012 to 2021.
   Google Scholar
• Statistical Package for the Social Sciences (SPSS) version 25.0. (2020).
   Google Scholar
• Taherdoost, H. (2016, August 10). Validity and reliability of the research instrument; how to test the validation of a questionnaire/survey in a research. How to test the validation of a questionnaire/survey in a research.
   Google Scholar
• Tang, K. H. D. (2021). From movement control to national recovery plan: Malaysia’s strategy to live with COVID-19. International Journal of Science and Healthcare Research, 6(4), 286–292. https://doi.org/10.52403/ijshr.20211040
   Google Scholar
• Van Grootheest, K., & de Jong-van den Berg, L. (2004). Patients’ role in reporting adverse drug reactions. Expert Opinion on Drug Safety, 3(4), 363–368. https://doi.org/10.1517/14740338.3.4.363
   PubMedGoogle Scholar
• Vogel, G. (2021). Mixing vaccines may boost immune responses. American Association for the Advancement of Science.
   Google Scholar
• Wang, S., Parker, C., Taaffe, J., Solórzano, A., García-Sastre, A., & Lu, S. (2008). Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine, 26(29–30), 3626–3633. https://doi.org/10.1016/j.vaccine.2008.04.073
   PubMed Web of Science ®Google Scholar
• Wise, J. (2021). COVID-19: People who have had infection might only need one dose of mRNA vaccine. British Medical Journal Publishing Group.
   Google Scholar
• Yamane, T. (1967). A simplified formula to calculate sample size. Google Scholar.
   Google Scholar
• Zainul, H. (2021, June 27). As Malaysia’s Covid-19 vaccination drive revs up, sceptics threaten to spoil the party.
   Google Scholar
• Zhai, S., Zhang, Z., Liao, J., & Cui, X. (2023). Learning from real world data about combinatorial treatment selection for COVID-19. Frontiers in Artificial Intelligence, 6, 1123285. https://doi.org/10.3389/frai.2023.1123285
   PubMedGoogle Scholar
• Zhang, M.-X., Zhang, T.-T., Shi, G.-F., Cheng, F.-M., Zheng, Y.-M., Tung, T.-H., & Chen, H.-X. (2021). Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China. Expert Review of Vaccines, 20(7), 891–898. https://doi.org/10.1080/14760584.2021.1925112
   PubMed Web of Science ®Google Scholar